Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04639427

Acronym

Co-VIS

Enrollment

Registered

2020-11-20

Start date

2021-02-08

Completion date

2021-07-31

Last updated

2021-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Oral-Linguo-Facial Praxies

Keywords

Oral-Linguo-Facial praxies, Covid19, speech therapy rehabilitation

Brief summary

The primary objective of the study is to compare the effectiveness of the use of a transparent covering visor with that of the face mask, with or without the use of video sequences, for speech therapy rehabilitation of oral-linguo-facial praxies in the context of the COVID 19 epidemic.

Detailed description

Statistic analysis: single case experimental design (SCED) method.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Aged \>= 18 years; * Hospitalization for more than 2 weeks prior to enrollment in the adult post intensive care rehabilitation care unit (PICRU) of Raymond Poincaré hospital in Garches; * With oral-linguo-facial praxis disorders whatever the cause; * Has been informed and not in opposition to participation of the study.

Exclusion criteria

* Patient with fever or any suspect symptom of a SARS-CoV2 infection; * Planned discharge of hospital in 2 weeks; * Patient with cognitive, phasic or vigilance disorders preventing to understand the study; * Under guardianship or curator; * Patient Under french AME scheme.

Design outcomes

Primary

Measure	Time frame
Oral-Linguo-Facial Motricity Test	throughtout of the study, an average of 2 weeks

Countries

France

Contacts

Primary ContactJulie PAQUEREAU, MD

julie.paquereau@aphp.fr+ 33 (0)1 47 10 79 00

Outcome results